Dentin sialophosphoprotein (DSPP) gene-silencing inhibits key tumorigenic activities in human oral cancer cell line, OSC2

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Joshi, Rajeshree ^a   Tawfik, Amany ^a   Edeh, Nneka ^a   Mccloud, Veronica ^a   Looney, Stephen ^a   Lewis, Jill ^a   Hsu, Stephen ^a   Ogbureke, Kalu U E ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLINE; DENTIN SIALOPHOSPHOPROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; KI 67 ANTIGEN; MESSENGER RNA; PHOSPHOPROTEIN; PROTEIN P53; PUROMYCIN; SHORT HAIRPIN RNA; STROMELYSIN; TETRAZOLIUM; UNCLASSIFIED DRUG; VASCULOTROPIN; ANTINEOPLASTIC AGENT; SCLEROPROTEIN; SIALOGLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENIC ACTIVITY; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL INVASION; CELL STRUCTURE; CELL VIABILITY; COLONY FORMING UNIT; CONTROLLED STUDY; DENSITOMETRY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; MOUTH CANCER; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; UPREGULATION; VIRUS PARTICLE; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CELL MOTION; CYTOLOGY; DRUG EFFECT; EXPERIMENTAL NEOPLASM; GENETICS; KERATINOCYTE; METABOLISM; MOUTH TUMOR; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CISPLATIN; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PHOSPHOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIALOGLYCOPROTEINS; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 78649743356     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013974     Document Type: Article

References (30)

1. Fisher LW, Fedarko NS (2003) Six genes expressed in bones and teeth encode
2. George A, Sabsay B, Simonian PA, Veis A (1993) Characterization of a novel the current members of the SIBLING family of proteins. Connect Tissue Res dentin matrix acidic phosphoprotein. Implications for induction of biominer- 44(Suppl. 1): 33-40. alization.JBiol Chem 268: 12624-12630.
3. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA (1996) Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 317: 59-64.
4. Ogbureke KU, Fisher LW (2004) Expression of SIBLINGs and their partner MMPs in salivary glands. J Dent Res 83: 664-670.
5. Ogbureke KU, Fisher LW (2005) Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs). Kidney Int 68: 155-166.
6. Ogbureke KU, Fisher LW (2007) SIBLING expression patterns in duct epithelia reflect the degree of metabolic activity. J Histochem Cytochem 55: 403-409.
7. Bellahcène A, Castronovo V, Ogbureke KU, Fisher LW, Fedarko NS (2008) Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer 8: 212-226.
8. Fisher LW, Jain A, Tayback M, Fedarko NS (2004) Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers. Clin Cancer Res 10: 8501-8511.
9. Ogbureke KU, Nikitakis NG, Warburton G, Ord RA, Sauk JJ, et al. (2007) Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer. Oral Oncol 43: 920-932.
10. Ogbureke KU, Abdelsayed RA, Kushner H, Li L, Fisher LW (2010) Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma. Cancer 116: 1709-1717.
11. Osaki T, Tatemoto Y, Yoneda K, Yamamoto T (1994) Tumorigenicity of cell lines established from oral squamous cell carcinoma and its metastatic lymph nodes. Eur J Cancer B Oral Oncol 30B: 296-301.
12. Yoneda K, Yokoyama T, Yamamoto T, Hatabe T, Osaki T (1999) p53 gene mutation and p21 protein expression induced independently of p53, by TGF-beta and gamma-rays in squamous cell carcinoma cells. Eur J Cancer 35: 278-283.
13. Hsu S, Farrey K, Wataha J, Lewis J, Borke J, et al. (2005) Role of p21WAF1 in green tea polyphenol-induced growth arrest and apoptosis of oral carcinoma cells. Anticancer Res 25(A1): 63-67.
14. Chang SE, Foster S, Betts D, Marnock WE (1992) DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non-malignant phenotype. Int J Cancer 52: 896-902.
15. Hiraishi Y, Wada T, Nakatani K, Tojyo I, Matsumoto T, et al. (2008) EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines. Pathol Oncol Res 14: 39-43.
16. Zhou X, Zhang Z, Yang X, Chen W, Zhang P (2009) Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity. Int J Cancer 124: 483-489.
17. Fedarko NS, Jain A, Karadag A, Fisher LW (2004) Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases. FASEB J 18: 734-736.
18. Qin C, Baba O, Butler WT (2004) Postranslational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med 15: 126-136.
19. Jain A, McKnight DA, Fisher LW, Humphrey EB, Mangold LA, et al. (2009) Small integrin-binding proteins as serum markers for prostate cancer detection. Clin Cancer Res 15: 5199-5207.
20. von Marshall Z, Fisher LW (2010) Dentin sialophoshoprotein (DSPP) is cleaved into its two natural dentin matrix products by three isoforms of bone morphogenetic protein-1 (BMP1). Matrix Biol 29: 295-303.
21. Veis A, Perry A (1967) The phosphoprotein of the dentin matrix. Biochemistry 6: 2409-2416.
22. Kim SH, Cho NH, Kim K, Lee JS, Koo BS, et al. (2006) Correlation of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. J Surg Oncol 93: 330-337.
23. Dang D, Yang Y, Li X, Atakilit A, Regezi, J, et al. (2004) Matrix metalloproteinases and TGF-beta 1 modulate oral tumor cell matrix. Biochem Biophys Res Commun 316: 937-942.
24. Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones TM (2010) A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomarkers Prev 19: 574-587.
25. Arora S, Kaur J, Sharma C, Mathur M, Bahadur S, et al. (2005) Stromlysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res 11: 2272-2284.
26. Coussens LM, Fingleton B, Matrisian LM (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392.
27. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
28. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
29. Johnstone S, Logan RM (2006) The role of vascular endothelial growth factor (VEGF) in oral dysplasia and squamous cell carcinoma. Oral Oncol 42: 337-342.
30. Karadag A, Ogbureke KU, Fedarko NS, Fisher LW (2004) Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion. J Natl cancer Inst 96: 956-965.